CMMS in Life Sciences is Different with Chris Tencza

Podcast: CMMSradio · CMMSradio

Opublikowano: 2026-11-02

In this CMMSradio episode, CMMSradio talks with Chris Tencza of Blue Mountain about why Computerized Maintenance Management Systems (CMMS) and Enterprise Asset Management (EAM) work very differently in the highly regulated life sciences industry (pharma, biotech, medical devices, cell & gene therapy, etc.).Why life sciences is uniqueIn regulated manufacturing, a maintenance record isn’t just an operational tool — it is audit evidence. Compliance (GxP, 21 CFR Part 11, GAMP 5, etc.) is non-negotiable. Generic, horizontal CMMS platforms often force companies into heavy customization and lengthy validation cycles, creating risk and cost.Purpose-built vs. adapted systemsBlue Mountain’s Regulatory Asset Manager (RAM) was design...